See more : Berkshire Hathaway Inc. (BRK-B) Income Statement Analysis – Financial Results
Complete financial analysis of TripSitter Clinic Ltd. (TSTTF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TripSitter Clinic Ltd., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- TomaGold Corporation (TOGOF) Income Statement Analysis – Financial Results
- PPS International (Holdings) Limited (8201.HK) Income Statement Analysis – Financial Results
- ArborGen Holdings Limited (ARB.NZ) Income Statement Analysis – Financial Results
- G.M. Breweries Limited (GMBREW.NS) Income Statement Analysis – Financial Results
- Viemed Healthcare, Inc. (VMD.TO) Income Statement Analysis – Financial Results
TripSitter Clinic Ltd. (TSTTF)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.tripsitter.clinic
About TripSitter Clinic Ltd.
TripSitter Clinic Ltd. operates a consultative virtual clinic and tele-health platform that connects patients to a licensed physician who can evaluate for a prescribed treatment program of low-dose oral ketamine medication in the United States. Its platform covers treatment for depression, anxiety, post-traumatic stress disorders, bipolar disorders, and obsessive-compulsive disorders. The company's treatment subscription plan includes consultation with a physician, oral ketamine prescription medication, treatment sessions with a licensed medical practitioner, and messaging with a licensed medical practitioner. It serves clients in California, Illinois, Arizona, Colorado, Michigan, Washington, Florida, New York, Ohio, and Virginia. TripSitter Clinic Ltd. is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 13.98K | 488.30K | 87.22K | 0.00 |
| Cost of Revenue | 18.68K | 349.59K | 641.82K | 0.00 |
| Gross Profit | -4.70K | 138.71K | -554.60K | 0.00 |
| Gross Profit Ratio | -33.65% | 28.41% | -635.85% | 0.00% |
| Research & Development | 3.10K | 286.27K | 286.27K | 0.00 |
| General & Administrative | 353.08K | 1.33M | 2.09M | 178.17K |
| Selling & Marketing | 4.26K | 486.61K | 273.02K | 0.00 |
| SG&A | 357.34K | 1.82M | 2.36M | 178.17K |
| Other Expenses | 0.00 | 0.00 | -298.86K | 0.00 |
| Operating Expenses | 13.98K | 2.35M | 2.35M | 178.17K |
| Cost & Expenses | 362.46K | 2.35M | 2.36M | 178.17K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 15.89M | 0.00 |
| Depreciation & Amortization | 4.00 | 228.49K | -15.89M | 206.30K |
| EBITDA | -348.48K | -1.85M | -10.22M | -177.59K |
| EBITDA Ratio | -2,493.60% | -379.34% | 6,502.31% | 0.00% |
| Operating Income | -348.48K | -1.85M | 21.56M | -177.59K |
| Operating Income Ratio | -2,493.62% | -379.34% | 24,721.98% | 0.00% |
| Total Other Income/Expenses | 43.62K | -8.34K | -7.95M | -1.16K |
| Income Before Tax | -304.86K | -1.87M | -10.22M | -178.75K |
| Income Before Tax Ratio | -2,181.49% | -382.75% | -11,717.35% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 15.89M | 579.00 |
| Net Income | -304.86K | -1.87M | -26.11M | -179.33K |
| Net Income Ratio | -2,181.49% | -382.75% | -29,937.02% | 0.00% |
| EPS | 0.00 | -0.03 | -0.43 | 0.00 |
| EPS Diluted | 0.00 | -0.03 | -0.43 | 0.00 |
| Weighted Avg Shares Out | 66.58M | 60.58M | 60.58M | 302.41M |
| Weighted Avg Shares Out (Dil) | 66.58M | 60.58M | 60.58M | 302.41M |
Source: https://incomestatements.info
Category: Stock Reports